GLPwatch

Free Fatty Acid Effects In Type 2 Diabetes

NCT07677995 · Enrolling by invitation

Last updated 2026-07-13

This clinical trial tests how omega-3 fatty acids affect blood sugar levels in adults with type 2 diabetes over 28 days.

Status Enrolling by invitation Only people invited by the researchers can join.
Phase Not applicable Not a phased drug trial (e.g. a device or behavioral study).
Type Interventional (clinical trial)
Design Randomized, single-blind treatment study
Participants 60 people Planned (estimated).
Who can join Ages 18+ · all sexes
Timeline Started 2026-07 · est. completion 2027-02
Where 1 site · United Kingdom

What this study is testing ClinicalTrials.gov NCT07677995 ↗

Description as written by the study sponsor.

Omega-3 fatty acids are natural fats found in foods such as oily fish and flaxseed. Omega-3 fatty acids have been found to have positive effects on cardiovascular health, but there is less evidence on if they can help manage blood glucose in individuals with both cardiovascular disease and type 2 diabetes. This study will investigate whether the beneficial effects found in omega-3 fatty acids such as lowered blood glucose and reduced inflammation - both of which are important for managing type 2 diabetes and cardiovascular disease, can be beneficial for individuals with type 2 diabetes. As omega-3 fatty acids are already found naturally in food, and are already available as supplements, they could be a safe option to help manage these diseases. The aim of this study is to investigate if omega-3 fatty acids can slow down the progression of type 2 diabetes and reduce the risk of cardiovascular disease in individuals with type 2 diabetes.

Treatments tested

Main thing measuredTo evaluate the change in fasting glucose from baseline after 28 days of treatment, compared to each treatment group and placebo.
SponsorUniversity of Ulster
Conditions studiedType 2 Diabetes, Cardiovascular Disease, Omega-3 Fatty Acids
GLP-1 drugs

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT07677995 ↗